Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large-cell lymphomas. Case report.
暂无分享,去创建一个
E. Jaffe | M. Raffeld | T. Fest | I. Magrath | T. Otsuki | M. Tsokos | D. Kingma | K. Frekko | A. Shad | E. Werner | Å. Werner
[1] E. Jaffe,et al. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. , 1996, Leukemia.
[2] I. Orengo,et al. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients , 1995, The Lancet.
[3] E. Cesarman,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.
[4] Yi Fang Liu,et al. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. , 1995, Blood.
[5] R. Parmley,et al. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. , 1995, The New England journal of medicine.
[6] J. Locker,et al. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. , 1995, The New England journal of medicine.
[7] E. Cesarman,et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. , 1995, Blood.
[8] E. Cesarman,et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.
[9] B. Andresen,et al. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. , 1994, Blood.
[10] R. Braylan,et al. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. Low grade B-cell lymphoproliferative disorders of nonfollicular center cell type. , 1994, Human pathology.
[11] N. Raab-Traub,et al. Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas , 1994, Journal of virology.
[12] R. Mertelsmann,et al. BCL-2 induction is part of the strategy of Epstein-Barr virus. , 1994, Leukemia & lymphoma.
[13] E. Jaffe,et al. Epstein‐Barr Virus Is Infrequently Identified in Non‐Hodgkin's Lymphomas Associated with Hodgkin's Disease , 1994, The American journal of surgical pathology.
[14] S. Hamilton-Dutoit,et al. Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas , 1994 .
[15] P. Brousset,et al. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. , 1993, Blood.
[16] E. Jaffe,et al. Epstein-Barr virus-associated T-cell lymphoma in a renal transplant patient. , 1993, The American journal of surgical pathology.
[17] W. Chan,et al. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease [published erratum appears in Blood 1993 Oct 1;82(7):2268] , 1993 .
[18] G. Winberg,et al. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. , 1993, Oncogene.
[19] D. Thorley-Lawson,et al. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts , 1993, Journal of virology.
[20] D. Shibata,et al. Epstein-Barr virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt's lymphomas. , 1992, Leukemia.
[21] L. Young,et al. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage. , 1992, Virology.
[22] R. Shapiro,et al. B‐cell lymphoproliferative disorders after bone marrow transplant. An analysis of ten cases with emphasis on epstein–barr virus detection by in situ hybridization , 1991, Cancer.
[23] E. Jaffe,et al. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma. , 1991, American journal of clinical pathology.
[24] E. Kieff,et al. Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death , 1991, Cell.
[25] W. Hammerschmidt,et al. The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels , 1989, Journal of virology.
[26] Sullivan Jl. Epstein-Barr virus and lymphoproliferative disorders. , 1988 .
[27] E. Kieff,et al. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells , 1985, Cell.
[28] B. Barrell,et al. Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8 , 1985, Journal of virology.
[29] J. Sklar,et al. LYMPHOPROLIFERATIVE DISORDERS IN CARDIAC TRANSPLANT RECIPIENTS ARE MULTICLONAL LYMPHOMAS , 1984, The Lancet.